What does a serum anti‑Müllerian hormone (AMH) level of 19.4 pmol/L indicate about ovarian reserve in a reproductive‑aged woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

AMH of 19.4 pmol/L Indicates Normal to Low-Normal Ovarian Reserve

An AMH level of 19.4 pmol/L (approximately 2.7 ng/mL) falls within the normal to low-normal range for ovarian reserve in reproductive-aged women, though interpretation must be age-specific as AMH declines progressively with age.

Age-Specific Interpretation

The clinical significance of this AMH value depends critically on the patient's age:

  • Under age 35: This level is low-normal to slightly reduced, suggesting ovarian reserve below the median for age but not necessarily indicating imminent ovarian failure 1, 2
  • Ages 35-40: This represents a normal to low-normal value, consistent with expected age-related decline 3, 4
  • Over age 40: This is within expected normal range for this age group 2

AMH levels peak before age 25 years, with mean levels halving by age 36 and falling to a quarter of peak values by age 40 1. The 19.4 pmol/L value would fall approximately at or below the 50th percentile for women under 35, but within normal range for older reproductive-aged women 1, 2.

Clinical Implications

Fertility Potential

This AMH level does NOT predict natural fertility or time-to-pregnancy in the general population. Multiple large prospective studies have demonstrated that AMH levels above 0.7 ng/mL (5 pmol/L) are not associated with differences in fecundability or pregnancy rates after 12 cycles of attempting conception when adjusted for age 5. Since 19.4 pmol/L is well above this threshold, natural fertility potential should be considered normal for age.

Assisted Reproductive Technology Context

For women undergoing IVF/ICSI, this AMH level suggests:

  • Adequate ovarian response expected during controlled ovarian stimulation 4
  • Low risk of ovarian hyperstimulation syndrome (OHSS), as risk increases significantly above 20 pmol/L 1
  • Not predictive of poor response, which typically occurs with AMH <7 pmol/L 3, 4

Miscarriage Risk

AMH levels below 7.14-7.85 pmol/L have been associated with modestly increased miscarriage risk (OR 1.35) in women conceiving through ART 6. At 19.4 pmol/L, this patient is well above the threshold associated with increased miscarriage risk.

What This Level Does NOT Indicate

Critical caveats:

  • Not polycystic ovary syndrome (PCOS): PCOS is suggested by AMH ≥36 pmol/L, with 72% of PCOS patients having AMH in the top quartile for age 7, 1. This value is below the PCOS threshold.

  • Not premature ovarian insufficiency (POI): POI is characterized by AMH levels <8 pmol/L with 85% sensitivity and 100% specificity 8. This level excludes POI.

  • Not predictive of imminent menopause: While AMH can predict menopause timing in women over 40, a level of 19.4 pmol/L suggests several years remain before menopause 2, 8

Age-Specific Caution

If the patient is under age 25, exercise extra caution when interpreting this AMH value 9. AMH can fluctuate significantly throughout the menstrual cycle in young women, and age-specific reference ranges are less well-established in this population 9.

Recommended Clinical Action

Based on this AMH level:

  1. Correlate with patient age to determine if value is appropriate for reproductive stage
  2. Obtain menstrual history - regular cycles suggest adequate ovarian function regardless of AMH 9
  3. If fertility assessment desired and age >35: Consider antral follicle count (AFC) by ultrasound for complementary assessment, as AMH correlates strongly with AFC (r=0.836) 1, 4
  4. If irregular menses or amenorrhea present: Measure FSH and estradiol to assess ovarian function, as AMH alone does not diagnose ovarian dysfunction 9, 10, 9
  5. Counsel regarding reproductive planning: If age >35 and desiring future pregnancy, advise against prolonged delay given age-related fertility decline (independent of AMH) 10, 3

Key Pitfall to Avoid

Do not use this AMH value alone to counsel about natural fertility potential or recommend immediate fertility treatment. AMH reflects ovarian reserve quantity but does not predict natural conception rates in the general population 5, 11. Age remains the strongest predictor of fertility and pregnancy outcomes, independent of AMH levels 5, 3, 4.

References

Research

Anti-Müllerian hormone as a predictor of reproductive potential.

Current opinion in endocrinology, diabetes, and obesity, 2018

Guideline

anti-müllerian hormone in pcos: a review informing international guidelines.

Trends in Endocrinology and Metabolism, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.